Home » News

Why Test Your Employees?

If you aren’t testing your employees, you’re probably losing money. Estimates are that a single drug using employee costs his employer between $9,000 and $21,000 per year.  The cost to enroll one employee in a random testing program in our system is less than $100 per year.* […]

Unparalleled Experience

With over 20 years experience and over 3000 client companies including government agencies and private enterprises large and small, Bio-Med is the northwest's first choice for drug-testing program administration and services.  Unparalleled experience, expertise and customer service make us an easy choice for businesses large and small, private and public, local and national, DOT-regulated and [...]

DOT-Consortium TPA

Navigating the complexities of DOT regulations is difficult, complex and requires countless staff hours.  Bio-Med is here to assist employers in the administration of their random testing programs to keep DOT compliance as seamless as possible. Our services include managing the random testing pool, specimen collections, policy consultation, driver history checks and supervisor training, etc. [...]

USA Today Article Discusses Two Sides of MJ/Alcohol Debate

The safeness of marijuana when compared to alcohol has become front and center since the President's comment comparing the two. Here's an article from USA Today that gives the two sides of the debate from a medical perspective.

Perception of Marijuana as a “Safe Drug” is Scientifically Inaccurate

Cannabis affects addiction processes in the adolescent brain Released: 8/27/2013 6:15 AM EDT Source Newsroom: Universite de Montreal more news from this source   Newswise — NEW YORK AND MONTREAL, AUGUST 27, 2013 – The nature of the teenage brain makes users of cannabis amongst this population particularly at risk of developing addictive behaviors and suffering other [...]

Bio-Med Has Moved!

Bio-Med Testing Services in Salem has moved! Please update your records with our new address: Bio-Med Testing Services, Inc. 3110 25th St SE Salem, OR 97302 Phone/Fax remain the same.

US Court of Appeals Denies Petition to Reclassify Marijuana

In a landmark decision issued on January 23rd, the US Court of Appeals rejected a petition to consider the Federal reclassification of marijuana from a Schedule I substance in the Control Substance Act. You can read the text of the decision here. You can read an NBC News article about the decision here. What this [...]